Happy New Year – 2016

It’s been an interesting year. When I started this site I really didn’t know what was going to happen… in most respects, it has exceeded my expectations. A Few Opening Remarks On a positive note, I genuinely felt support for the mission of trying to create a fresh dialogue around the quality and transparency of ASX-listed companies operating in this…

Investor Relations and ASX Biosciences : Part of the Problem

In the last couple of weeks we have seen a couple of interesting movements between the corporate and investor relations world, a “new” arrival and an “old” departure. Firstly, in Prima Biomed’s (ASX :PRR) most recent investment letter we quietly learned of Stuart Roberts’ departure from Prima Biomed as Head of Investor Relations, and the appointment of…

Ouch, Invion…

Wow! Some days I just can’t get the timing of information and commentary right. No sooner had I posted on Invion (ASX : IVX), commenting on their lousy Lupus data announcement, then they “released the hounds” on their private placement. I suppose given the trading halt, this was anticipated and so yes, I am feeling like…

The Incest of ASX Biopharma

It’s pretty hard to beat the Brits when it comes to situational comedy. As a dual-Australian/Canadian national educated in the UK, I suppose I have an intrinsic affinity for that dry, offhand style of humour. A few years ago, I stumbled across a brilliant comedy skit that visually captures precisely the fundamental reason why ASX biopharma is…

Close call, Prima…

Congratulations Prima Biomed (ASX : PRR). You survived to fight another day. But please note that the Ridgeback deal was a close-call (55% : 45%) and the feedback that you should be taking on-board is that many of your shareholders have some major issues with your attitude and performance. Let this day represent the beginning of…

Note to Prima Biomed Shareholders…

By now, the proxy forms are in and the majority of shareholders will have already cast their vote regarding the five resolutions for the EGM meeting on Friday. Obviously a show of hands in a shareholder meeting is not going to be the deciding factor here. I have been unabashedly clear in my position that…

The Bioshares 2015 : “Long Tail” Awards

Unfortunately, I will not be at Bioshares in New Zealand this weekend to present these well-deserved awards on behalf of the dedicated readers of The Long Tail. However, I have ordered a crate of North Korean Kumdang-2 as the prize for these awards and as soon as it clears AQIS, I will be sure and distribute…